Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leptin and prostate cancer.

S Chang1, S D Hursting, J H Contois

  • 1Department of Epidemiology, Box 189, University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030-4095, USA. Schang@mdanderson.org

The Prostate
|February 15, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic variants in the folate metabolic pathway genes predict cutaneous melanoma-specific survival.

The British journal of dermatology·2020
Same author

Innovations in risk-stratification and treatment of Veterans with oropharynx cancer; roadmap of the 2019 Field Based Meeting.

Oral oncology·2019
Same author

Genome-wide association study across European and African American ancestries identifies a SNP in DNMT3B contributing to nicotine dependence.

Molecular psychiatry·2017
Same author

Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence.

Translational psychiatry·2015
Same author

Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Genes and immunity·2015
Same author

Integrating chemohormonal therapy and surgery in known or suspected lymph node metastatic prostate cancer.

Prostate cancer and prostatic diseases·2015
Same journal

Salvage Androgen Deprivation Therapy Use After Definitive Radiotherapy With vs Without Androgen Deprivation Therapy in Prostate Cancer.

The Prostate·2026
Same journal

A Simple Cell Culture Assay for Human Prostatic Branching Morphogenesis Spotlights Bone Morphogenetic Protein Signaling as a Therapeutic Target in Benign Prostatic Hyperplasia.

The Prostate·2026
Same journal

Temporal Trends of Metastatic Prostate Cancer in the Prostate-Specific Membrane Antigen Positron Emission Tomography Era in the United States.

The Prostate·2026
Same journal

Holmium Laser Enucleation of the Prostate (HoLEP) With Proactive Preservation of One Lateral Lobe: A Technique for Benign Prostatic Hyperplasia to Preserve Sexual Function.

The Prostate·2026
Same journal

Clinical Variable-Based Machine Learning for Predicting Early mCRPC Using Exclusively Clinical Variables: Development and Multicenter External Validation.

The Prostate·2026
Same journal

Association Between Intraoperative Prostate Bed Blood Flow and Postoperative Lower Urinary Tract Symptoms After Robot-Assisted Radical Prostatectomy.

The Prostate·2026
See all related articles

Elevated leptin levels, a hormone linked to obesity, are associated with a higher risk of clinically relevant prostate cancer. This finding suggests leptin may influence prostate cancer development, potentially interacting with testosterone and body composition factors.

Area of Science:

  • Oncology
  • Endocrinology
  • Epidemiology

Background:

  • Prostate cancer mortality varies geographically, suggesting environmental factors influence its development.
  • Adiposity and related hormones, such as leptin, are potential contributors to prostate carcinogenesis.

Purpose of the Study:

  • To investigate the association between plasma leptin concentrations and clinically relevant prostate cancer.
  • To identify determinants of high-volume prostate cancer, including adiposity-related hormones.

Main Methods:

  • Case-control study comparing 48 men with small tumors (<0.5 cc) to 151 men with high-volume disease or extraprostatic extension.
  • Plasma leptin concentrations were measured and compared between groups.
  • Analyses were matched for age and year of diagnosis and stratified by testosterone, height, and BMI.

Related Experiment Videos

Main Results:

  • Men with high-volume prostate cancer had significantly higher plasma leptin concentrations.
  • Elevated leptin was associated with an increased risk of high-volume disease (OR=2.35).
  • High leptin combined with high testosterone (OR=9.73) or greater height (OR=3.67) further increased risk.

Conclusions:

  • Leptin may play a role in the risk of clinically relevant prostate cancer.
  • Testosterone levels, stature, and obesity-related factors may mediate leptin's effect on prostate cancer risk.